This observation is likely the result of the enrichment of FOLH1 in ccRCC; thus, analysis by FOLH1-high and -low tumors in the overall cohort largely reflected a comparative analysis between ccRCC and nccRCC, which historically portends a worse progression [42]. The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.